Rhythm Pharmaceuticals
RYTM
₹4,526
Share price
-3.34%
Change (1 day)
27.22%
Change (1 year)
Categories
P/S ratio for Rhythm Pharmaceuticals (RYTM)
P/S ratio as of April 2025 (TTM): 26.6
According to Rhythm Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 21.0. At the end of 2024 the company had a P/S ratio of 26.3.
P/S ratio history for Rhythm Pharmaceuticals from 2017 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 26.3 | -25.17% |
| 2023 | 35.1 | -49.46% |
| 2022 | 69.4 | -56.37% |
| 2021 | 159 | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |